News Hub | News Direct

All Industries


Article thumbnail News Release

Fathom Nickel provides preliminary update on recent Gochager Lake drilling

Fathom Nickel

Fathom Nickel CEO Ian Fraser joined Steve Darling from Proactive to share an exploration update regarding the company's Gochager Lake Project. Although official assay results are pending, Fathom Nickel has been actively evaluating and interpreting preliminary data, including pXRF (portable X-ray fluorescence) and borehole electromagnetic data. Fraser revealed that the drillholes completed at the Gochager Lake Project have intersected multiple zones of semi-massive sulphide mineralization. These zones are characterized by being highly nickeliferous and conductive. Moreover, they exhibit a steeply plunging orientation, resembling a "chute," within a broader halo of nickel-bearing, disseminated sulphide mineralization. Fathom Nickel is now in the process of utilizing all available data to prepare for an upcoming drill program scheduled for the first quarter of 2024. This program is expected to build upon the findings from the recent drilling and contribute to a more comprehensive understanding of the Gochager Lake Project's potential. The presence of high-quality nickel-bearing mineralization in the project area indicates promising prospects for Fathom Nickel's exploration efforts. As the company continues to gather data and advance its drilling program, it aims to unlock the full potential of the Gochager Lake Project and contribute to the growing demand for nickel resources in various industries. Contact Details Proactive Canada +1 604-688-8158 na-editorial@proactiveinvestors.com

November 14, 2023 01:57 PM Eastern Standard Time

Video
Article thumbnail News Release

Nevis Brands announces company is expanding into Michigan with signature brand Major

Nevis Brands

Nevis Brands CEO John Kueber joined Steve Darling from Proactive to share significant news regarding the company's expansion into Michigan, marking its eighth state in the cannabis market. Nevis Brands has secured an exclusive agreement with Emerald Canning Partners to produce and distribute Major products in the state of Michigan, subject to approval by the Michigan Cannabis Regulatory Agency. Michigan is a strategically important market for Nevis Brands, as it witnessed cannabis sales totaling $2.3 billion in 2022, and it is expected to exceed the $3 billion mark in 2023. This makes Michigan the second territory in the Eastern United States where Nevis is establishing a licensee. Under the agreement with Emerald Canning Partners, Nevis Brands will have exclusive rights to produce and distribute all five flavors of Major, including Sunset Pink Lemonade, Pacific Blue Raspberry, Sacred Grape, Volcanic Orange Mango, and Passionfruit. Major is a dosable 100mg THC beverage known for delivering the effects of cannabis within 10-20 minutes of consumption. This expansion into Michigan represents a significant step for Nevis Brands as it continues to grow its presence in the rapidly evolving cannabis market. With its innovative Major product line and strategic partnerships, Nevis is well-positioned to capitalize on the increasing demand for cannabis products and provide consumers with unique and high-quality options. Contact Details Proactive Canada +1 604-688-8158 na-editorial@proactiveinvestors.com

November 14, 2023 01:49 PM Eastern Standard Time

Video
Article thumbnail News Release

Guardian Angel Carers Newark and Lincoln Home Care Crowned New Business of the Year at Lincolnshire Marketing Awards

Prodigy Press Wire

A beacon of dedication, innovation, and superior service in the care industry, Guardian Angel Carers – Lincoln and Newark have clinched the title of New Business of the Year at the Lincolnshire Marketing Awards, held on 13th September 2023 at The Doubletree by Hilton. These awards, which mark the pinnacle of business excellence in Lincolnshire, underscore the achievements of enterprises established in the last two years. They serve as an emblematic recognition of the zest, creativity, and passion of the local business community. Under the steadfast leadership of Andrew Smith, the Guardian Angel Carers team in Lincoln and Newark has demonstrated an unparalleled commitment to their mission. Andy Smith, who boasts over two decades of experience in the hospitality trade and over 3 impactful years in the care sector, has carved a niche by bringing the growing popularity of Guardian Angel Carers home care services to his local community. With an unwavering ethos of assisting local residents and generating employment in Lincoln and Newark, he has been instrumental in propelling the areas continuing success. Bridging the gap between caring and compassion, the Newark and Lincoln home care territory is an esteemed part of the Guardian Angel Carers network. Clients they support benefit from award-winning training and care plans meticulously tailored to cater to their exact needs. Andrew Smith commented on the accolade, "This award is not just a recognition for our business but a testament to our dedicated home care team and the trust our community has shown in us. Our commitment remains absolute - to deliver unparalleled care and support." Lincoln and Newark home care territory of Guardian Angel Carers was awarded New Business of the Year As social care becomes evermore focused on supporting people within their own homes, Guardian Angel Carers ’ role in shaping a resilient, effective, and compassionate home care model is undeniable. Their success underscores the growing preference among UK families for care options that prioritise personal respect, tailor-made support, and the comfort of care at home over institutional settings. This trend signals a positive shift towards more dignified care for adults looking for support and highlights the true value of services provided within the home care sector. For more information on Guardian Angel Carers – Lincoln and Newark and their array of commendable services, please visit their website at www.gacarers.co.uk/lincoln-newark About Guardian Angel Carers - Lincoln and Newark: Guardian Angel Carers is a leading home care provider dedicated to delivering compassionate, personalised care services. With a strong focus on independence, dignity, and quality of life, the company supports individuals in the comfort of their own homes, offering a range of services from companionship to complex care nee ds. Media Contact: Andy Smith 01522 458780 www.gacarers.co.uk/lincoln-newark/ Publicist for Guardian Angel Carers *** Source Company – https://www.gacarers.co.uk/ Release ID: 805803

November 14, 2023 01:30 PM Eastern Standard Time

Image
Article thumbnail News Release

Markets will be keeping an eye on US-China meeting — OptionsDesk

Options Desk

OptionsDesk broker Rich Perry speaks to Thomas Warner from Proactive London about the upcoming week's market dynamics and potential market movers. As the new week kicked off, Perry acknowledges that it might be somewhat less eventful compared to recent blockbuster weeks in terms of major economic news, though he does highlight US Core inflation data coming later in the week. The data is of particular interest as market participants await insights into whether the Federal Reserve's maintenance of higher interest rates is affecting inflation trends. Thursday will bring standard US jobless claims, along with significant earnings reports from Walmart. The week concludes with UK retail sales data on Friday, providing insights into the strength of the UK consumer market. Outside of purely economic events, talk turns to the potentially significant meeting between US President Joe Biden and Chinese Premier Xi Jinping on the sidelines of the Asia-Pacific Economic Cooperation conference taking place in San Francisco this week. Recognising the potential impact on market sentiment, Perry emphasises the importance of monitoring the rhetoric and outcomes of this meeting. The discussions between the leaders of the world's two largest economies could introduce surprises or shocks, influencing global markets. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

November 14, 2023 01:28 PM Eastern Standard Time

Video
Article thumbnail News Release

Allied Corp Successfully Completes Another Commercial Shipment of THC Based Medical Cannabis from Colombia to Australia

Allied Corp.

Kelowna, BC, Canada – TheNewswire - November 14, 2023 - Allied Corp. ("Allied" or the “Company”) ( OTC:ALID ), a leading player in the international cannabis industry, is proud to announce that on the heels of last week’s successful shipment ( press release found here ) it has executed on another commercial export of THC based medical cannabis from its cultivation and processing facilities located in Colombia. The shipment has now successfully cleared Australian customs. This achievement is an additional testament to the company’s ability to comply with one of the world’s most stringent quality standards set by the Australian Therapeutics Goods Association (TGA) and unwavering commitment to providing high-quality medical cannabis products worldwide. With each successful commercial shipment into Australia, Allied Corp continues to reinforce a sustainable and robust supply chain as the company seeks to become one of the most reliable wholesale cannabis suppliers globally. These shipments serve as a testament to Allied's dedication to enhancing its presence in the market, nurturing relationships with key stakeholders, and showcasing its production competence.   “The achievement of the recent commercial shipments is the result of months of dedication and hard work by our team and marks a significant milestone for Allied as it continues to play a crucial role in addressing the diverse medical cannabis needs of patients and healthcare providers in the Australian market” says Michael Moses, CBDO. “As we look to the future, we are aligning our efforts and resources to strategically enter and thrive in growing markets, with Australia being a key focus” continues Juba Hadid, VP of Global Sales.   About Allied Corp. Allied Corp.  is an international cannabis company with its main production center in Colombia and is one of the few companies that has exported from Colombia internationally and the first company to export commercial cannabis flower from Colombia. By leveraging the Colombian advantages and its Canadian cannabis cultivation expertise, Allied offers consistent supply of premium cannabis product at scale and attractive prices, while meeting high quality standards, thus significantly de-risking its partners supply chain. Investor Relations: ir@allied.health 1-877-255-4337 Forward-Looking Statements: This press release contains “forward-looking information” within the meaning of applicable securities laws in Canada or the United States ( “forward-looking information”). Forward-looking information may relate to the Company’s future outlook and anticipated events, plans or results, and may include information regarding the Company’s objectives, goals, strategies, future revenue or performance and capital expenditures, and other information that is not historical information. Forward-looking information can often be identified by the use of terminology such as “believe,” “anticipate,” “plan,” “expect,” “pending,” “in process,” “intend,” “estimate,” “project,” “may,” “will,” “should,” “would,” “could,” “can,” the negatives thereof, variations thereon and similar expressions. The forward-looking information contained in this press release is based on the Company’s opinions, estimates and assumptions in light of management’s experience and perception of historical trends, current conditions and expected future developments, as well as other factors that management currently believes are appropriate and reasonable in the circumstances. Forward looking statements in this press release include the following: that Allied is leveraging the conditions in its Colombia grow operation and future Kelowna location to support its Research and Development efforts; that Allied is making important strides forward to position itself as a leader in the medical cannabis space, that Allied intends to make a series of proposed trademark and other intellectual property protection filings, as part of the Company’s Intellectual Property and Pharma Development (IP&PD) Strategy, statements respecting the joint development, manufacturing, and the introduction of TACTICAL RELIEF™ branded products. There can be no assurance that the underlying opinions, estimates and assumptions will prove to be correct. Risk factors that could cause actual results to differ materially from forward-looking information in this release include: the Company’s exposure to legal and regulatory risk; the effect of the legalization of adult-use cannabis in Canada and Colombia on the medical cannabis industry is unknown and may significantly and negatively affect the Company’s medical cannabis business; that the medical benefits, viability, safety, efficacy, dosing and social acceptance of cannabis are not as currently expected; that adverse changes or developments affecting the Company’s main or planned facilities may have an adverse effect on the Company; that the medical cannabis industry and market may not continue to exist or develop as anticipated or the Company may not be able to succeed in this market; risks related to completion of the greenhouse construction in Colombia, risks related to market competition; risks related to the proposed adult-use cannabis industry and market in Canada and Colombia including the Company’s ability to enter into or compete in such markets; that the Company has a limited operating history and a history of net losses and that it may not achieve or maintain profitability in the future; risks related to the Company’s current or proposed international operations; risks related to future third party strategic alliances or the expansion of currently existing relationships with third parties; that the Company may not be able to successfully identify and execute future acquisitions or dispositions or successfully manage the impacts of such transactions on its operations; risks inherent to the operation of an agricultural business; that the Company may be unable to attract, develop and retain key personnel; risks resulting from significant interruptions to the Company’s access to certain key inputs such as raw materials, electricity, water and other utilities; that the Company may be unable to transport its cannabis products to patients in a safe and efficient manner; risks related to recalls of the Company’s cannabis products or product liability or regulatory claims or actions involving the Company’s cannabis products; risks related to the Company’s reliance on pharmaceutical distributors; that the Company, or the cannabis industry more generally, may receive unfavorable publicity or become subject to negative consumer or investor perception; that certain events or developments in the cannabis industry more generally may impact the Company’s reputation or its relationships with customers or suppliers; that the Company may not be able to obtain adequate insurance coverage in respect of the risks that it faces, that the premiums for such insurance may not continue to be commercially justifiable or that there may be coverage limitations and other exclusions which may result in such insurance not being sufficient; that the Company may become subject to liability arising from fraudulent or illegal activity by its employees, contractors, consultants and others; that the Company may experience breaches of security at its facilities or losses as a result of the theft of its products; risks related to the Company’s information technology systems; that the Company may be unable to sustain its revenue growth and development; that the Company may be unable to expand its operations quickly enough to meet demand or manage its operations beyond their current scale; that the Company may be unable to secure adequate or reliable sources of necessary funding; risks related to, or associated with, the Company’s exposure to reporting requirements; risks related to conflicts of interest; risks related to fluctuations in foreign currency exchange rates; risks related to the Company’s potential exposure to greater-than-anticipated tax liabilities; risks related to the protection and enforcement of the Company’s intellectual property rights, or the intellectual property that it licenses from others; that the Company may become subject to allegations that it or its licensors are in violation of the intellectual property rights of third parties; that the Company may not realize the full benefit of the clinical trials or studies that it participates in; that the Company may not realize the full benefit of its licenses if the licensed material has less market appeal than expected and the licenses may not be profitable; as well as any other risks that may be further described in and the risk factors discussed in the Company's continuous disclosure including its Management's Discussion and Analysis sections in its Quarterly Reports on Form 10-Q, Annual Reports on Form 10-K and Current Reports on Form 8-K filed under the Company's profile at www.sec.gov. Although management has attempted to identify important risk factors that could cause actual results to differ materially from those contained in the forward-looking information in this presentation, there may be other risk factors not presently known to the Company or that the Company presently believes are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking information in this presentation. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. Accordingly, readers and viewers should not place undue reliance on forward-looking information, which speaks only as of the date made. The forward-looking information contained in this release represents the Company’s expectations as of the date of this release or the date indicated, regardless of the time of delivery of the presentation. The Company disclaims any intention, obligation or undertaking to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required under applicable securities laws.

November 14, 2023 01:25 PM Eastern Standard Time

Article thumbnail News Release

Immunic focusing on business development during Q4

Immunic Inc

Immunic Inc President and CEO Dr Daniel Vitt speaks to Thomas Warner from Proactive London after the Munich-based biotech company released a third-quarter update. Dr Vitt starts by describing the quarter as a "very eventful and positive quarter for us, dominated by a key message" - positive interim data from its Phase 2 CALLIPER trial of vidofludimus calcium in Progressive Multiple Sclerosis. The financial aspect was also discussed, with the company claiming a cash reserve of $60 million as of the last quarter. The interview highlights the company's efforts to bolster its intellectual property portfolio, citing a notice of allowance from the US Patent Office for the vidofludimous calcium dose strength patent. Dr Vitt discusses the company's focus on business development during the current quarter, expressing confidence in the data and molecules its bringing to discussions with potential partners. He says that "the focus for the company is clearly on the business development side... we [also] continue execution of the vidofludimous MS programs and also prepare a potential phase 2 clinical study for IMU-856." Contact Details Proactive United States +1 347-449-0879 na-editorial@proactiveinvestors.com

November 14, 2023 01:25 PM Eastern Standard Time

Video
Article thumbnail News Release

Caledonia Mining Corporation sees "very encouraging" signs at Blanket Gold mine

Caledonia Mining Corporation PLC

Caledonia Mining Corporation CEO Mark Learmonth speaks to Thomas Warner from Proactive London after the Zimbabwe-focused gold producer announced a third-quarter update. Learmonth explains that Caledonia Mining achieved some significant milestones during the quarter with gold production from its Blanket mine reaching nearly 22,000 ounces. The output helped the company reach a gross profit of $14 million for the quarter. While acknowledging a slight increase in operational costs, Learmonth expresses optimism, emphasising the company's commitment to addressing specific challenges, including higher overtime payments and unexpected electricity usage. Addressing the disappointing performance of the Bilboes Oxide Project, Learmonth clarified that it does not reflect on the quality of the underlying sulphide property. The company has decided to place the Bilboes Project on care and maintenance, redirecting efforts toward an ongoing feasibility study for the sulphide property. He adds that Caledonia has received an offer for its solar project, and negotiations are underway. Learmonth highlighted the company's cautious approach to development, emphasising a commitment to optimising shareholder value. Looking ahead, the company is working on refreshing the feasibility study for the Bilboes project, considering a new approach to minimise upfront capital costs. Learmonth expresses optimism about concluding negotiations on the solar project offer by year-end and providing a clear direction for future strategic developments in early 2024. Contact Details Proactive Investors +44 20 7989 0813 uk@proactiveinvestors.com

November 14, 2023 01:20 PM Eastern Standard Time

Video
Article thumbnail News Release

Intra Energy identifies additional pegmatites at Yalgarra

Intra Energy Corporation Ltd

Intra Energy Corporation Ltd (ASX:IEC) MD Ben Dunn tells Proactive the company has completed a second mapping and sampling campaign at the Yalgarra nickel-copper-PGE and lithium project, 70 kilometres east of Kalbarri in Western Australia. The field mapping campaign targeted the entire width of the northern end of the tenement including the previously identified pegmatite field located in the northeast corner. Multiple additional pegmatite outcrops have been identified including two coarse grained pegmatites with crystals up to 5 centimetres long.“Todd Hibberd is doing a fantastic job advancing our Yalgarra Project, as we continue to steadily move towards having several high-quality drill targets,” Dunn said. “Our permit of works has been approved and we are engaging with the Traditional Owners to get heritage clearance and once this has been approved, we look forward to commencing drilling. “Shareholders can be optimistic about multiple opportunities at Yalgarra, especially the lithium anomalisms which, if proved, could potentially be a new Western Australian lithium province. “At the same time, we are continuing work on our flagship Llama Lithium Project in Canada and expect to have updates on rock assays and LIDAR for shareholders in the coming weeks. “We have built a strong foundation over the last year and now look forward to 2024 as a year that could really propel IEC forward.” Contact Details Proactive Investors Jonathan Jackson +61 413 713 744 jonathan@proactiveinvestors.com

November 14, 2023 01:15 PM Eastern Standard Time

Video
Article thumbnail News Release

East Star Resources now "significantly closer" to JORC resource

East Star Resources PLC

East Star Resources PLC CEO Alex Walker speaks to Proactive after the Kazakhstan-focused gold, copper and rare earths explorer released an update on the assays from drilling at the Verkhuba Deposit on the Rudny Altai VMS belt. Walker expressed satisfaction with the ongoing program, noting the need to re-assay 62 samples that exceeded the detection limit. The preliminary indications confirm the expected copper and zinc mineralization and showcase a promising correlation between mineralised zones and historical data. While awaiting final results, Walker highlights notable intersections, such as 10m above 1% copper and just under 8 g/t of silver. This aligns well with historical results, raising optimism for the project's potential. With upcoming assays from areas outside Verkhuba and recent fundraising of £540,000, Walker says East Star Resources is well-funded for current and future programs. Walker anticipates significant advancements in their projects before the need for additional capital. The CEO also touched on the timeline for the JORC resource results, saying that the company is "significantly closer than we were previously." Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

November 14, 2023 01:08 PM Eastern Standard Time

Video
1 ... 435436437438439 ... 3447